Press release
Esophageal Cancer Therapeutics Market Research Report by Leading Key Players – Genentech, Sanofi-Aventis, Eli Lilly and Company, Ono Pharmaceutical Co., Merck & Co.,Johnson & Johnson Pharmaceutical Research & Development, Gilead Sciences, and Bristol-My
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/esophageal-cancer-therapeutics-market
Esophageal cancer involves formation of malignant cells in the tissues of the esophagus. Esophagus is a muscular tube that enable food and liquids to move from the throat to the stomach. The main types of esophageal cancer are adenocarcinoma and squamous cell carcinoma. Adenocarcinoma forms in cells that produce and release mucus and other fluids. Squamous cell carcinoma forms in flat cells lining the esophagus. Esophageal squamous cell carcinoma includes heavy alcohol consumption and smoking as major risk factors, with gastroesophageal reflux disease and Barrett esophagus further contributing as the risk factors of esophageal adenocarcinoma. Esophageal cancer has no early signs or symptoms; therefore, an advanced stage diagnosis is difficult.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/esophageal-cancer-therapeutics-market/report-sample
Some of the major drivers for the global esophageal cancer therapeutics market include combination therapies, treatment advancements, increasing number of regulatory approvals for esophageal cancer and a rise in the number of cancer treatment centers. Moreover, the launch of new drug therapies for esophageal cancer is expected to contribute as a key market driver in the near future. Also with a dense pipeline, many new drug candidates are expected to enter the global esophageal cancer therapeutics market. Safety concerns and efficacy of the treatment are the major factors that can hinder the market growth over the forecast period. Other factors hampering the market growth include low availability of drugs commercially and high cost of therapy for the treatment of esophageal cancer.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=esophageal-cancer-therapeutics-market
Genentech, Inc. markets Trastuzumab (Herceptin) in combination with cisplatin and a fluoropyrimidine (either capecitabine or 5-fluorouracil), for the treatment of patients with HER2-overexpressing metastatic gastric or gastroesophageal (GE) junction adenocarcinoma who were not treated for metastatic disease prior.
Some of the key players operating in the global esophageal cancer therapeutics market include Genentech, Inc., Sanofi-Aventis, Eli Lilly and Company, Ono Pharmaceutical Co., Ltd., Merck & Co., Inc., Johnson & Johnson Pharmaceutical Research & Development, LLC, Gilead Sciences, and Bristol-Myers Squibb, among others.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Esophageal Cancer Therapeutics Market Research Report by Leading Key Players – Genentech, Sanofi-Aventis, Eli Lilly and Company, Ono Pharmaceutical Co., Merck & Co.,Johnson & Johnson Pharmaceutical Research & Development, Gilead Sciences, and Bristol-My here
News-ID: 1552150 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for Esophageal
Rising Prevalence Of Chronic Esophageal Disorders Boosts The Esophageal Catheter …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Esophageal Catheters Market Size By 2025?
The market for esophageal catheters has experienced significant expansion recently. Its growth is projected to continue from a market size of $2.43 billion in 2024 to an increased value of $2.64 billion in 2025, reflecting a compound annual growth…
Evolving Market Trends In The Esophageal Dilator Industry: Advanced Solutions En …
The Esophageal Dilator Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Esophageal Dilator Market Size During the Forecast Period?
The esophageal dilator market size will grow from $1.49 billion in 2024 to $1.57 billion in 2025 at a CAGR of 5.2%. Growth…
Evolving Market Trends In The Esophageal Dysphagia Industry: Innovative Technolo …
The Esophageal Dysphagia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Esophageal Dysphagia Market Size During the Forecast Period?
The market size for esophageal dysphagia has seen robust growth in the past few years. Projections show that it is set to expand…
Key Trend Reshaping the Esophageal Dilator Market in 2025: Advanced Solutions En …
What combination of drivers is leading to accelerated growth in the esophageal dilator market?
The esophageal dilator market is expected to see growth driven by the increasing occurrence of esophageal disorders. These disorders refer to a range of conditions affecting the esophagus, responsible for transporting food and fluids from the mouth to the stomach. The escalated prevalence of such disorders can be linked to factors such as the growing instances of…
Advanced Solutions Enhanced Esophageal Dilator Market Trend: A Crucial Influence …
What Is the Expected Size and Growth Rate of the Esophageal Dilator Market?
The market size for esophageal dilators has experienced robust growth in the past few years. The market's value, estimated at $1.49 billion in 2024, is predicted to inflate to $1.57 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.2%. This positive trend during the historical period is primarily driven by factors such as an increase…
Top Factor Driving Esophageal Catheters Market Growth in 2025: Rising Prevalence …
How Big Is the Esophageal Catheters Market Expected to Be, and What Will Its Growth Rate Be?
The esophageal catheters market has experienced significant growth in recent years. It will grow from $2.43 billion in 2024 to $2.64 billion in 2025, at a CAGR of 8.6%. The growth can be attributed to advancements in critical care, the rise of cardiac and respiratory disorders, the use of minimally invasive procedures, and developments…
